A Study of Epigenetic Priming Using Decitabine With Front Line Induction Chemotherapy Compared With Immediate Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects.
Phase of Trial: Phase II
Latest Information Update: 15 Apr 2015
At a glance
- Drugs Cytarabine; Daunorubicin; Decitabine
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- Sponsors Eisai Inc; Eisai Medical Research
- 17 Nov 2010 Status changed from not yet recruiting to discontinued as reported by ClinicalTrials.gov.
- 13 Apr 2010 Planned initiation date changed from 1 Feb 2010 to 1 Jun 2010 as reported by ClinicalTrials.gov.
- 12 Aug 2009 Planned initiation date changed from 1 Oct 2009 to 1 Feb 2010 as reported by ClinicalTrials.gov.